cobas BKV, cobas EBV/BKV Control Kit, cobas Buffer Negative Control Kit
K-Number: K202215 · 2020-09-02
Device Summary
Frequently Asked Questions
What is the cobas BKV, cobas EBV/BKV Control Kit, cobas Buffer Negative Control Kit?
cobas BKV, cobas EBV/BKV Control Kit, cobas Buffer Negative Control Kit is a medical device that received FDA 510(k) clearance on 2020-09-02. It is manufactured by Roche Molecular Systems, Inc.. The 510(k) number is K202215.
When was cobas BKV, cobas EBV/BKV Control Kit, cobas Buffer Negative Control Kit approved by the FDA?
cobas BKV, cobas EBV/BKV Control Kit, cobas Buffer Negative Control Kit received FDA 510(k) clearance on 2020-09-02, under approval number K202215.
What company makes cobas BKV, cobas EBV/BKV Control Kit, cobas Buffer Negative Control Kit?
cobas BKV, cobas EBV/BKV Control Kit, cobas Buffer Negative Control Kit is manufactured by Roche Molecular Systems, Inc..
What is the FDA product code for cobas BKV, cobas EBV/BKV Control Kit, cobas Buffer Negative Control Kit?
The FDA product code for cobas BKV, cobas EBV/BKV Control Kit, cobas Buffer Negative Control Kit is QMI.
Related Clinical Trials
Other Devices by Roche Molecular Systems, Inc.
Related Devices (Code: QMI)
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.